Patient Selection

patient population

The OPTION Patient

Qualified OPTION candidates must meet all of the below criteria:

  1. ​​Have been diagnosed with NVAF​

  2. Have or will have an AF ablation to treat their AF symptoms​

  3. Have a CHADSVASC ≥ 2 (men) or ≥ 3 (women)​

  4. Are looking for options for stroke risk reduction post-ablation


​​Patients do not need to have an appropriate rationale to seek a non-pharmacologic alternative to OAC to participate in this study.​​


Consider the following questions when identifying candidates:

  1. What options do you recommend for your patients for stroke risk reduction post-atrial fibrillation ablation?

  2. Do your patients express concern about continuing long-term OACs post-ablation?

Why This Patient Population?

  • This is a large and growing population that is particularly well-suited to an alternative, like LAAC, for stroke rate reduction.

  • LAAC would enable these patients to stop OAC while managing their stroke risk in a procedure with a similar safety profile to ablation.

  • The recurrences of atrial fibrillation post-ablation are 3 to 7 times¹ more likely to be asymptomatic. Due to the lack of symptoms, post-ablation patients may feel better and decide to stop OAC and unknowingly increase their stroke risk.
1. January, CT. et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation. JACC. 2014; doi: 10.1016/j.jacc.2014.03.022